Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2003 1
2004 1
2005 2
2006 2
2007 1
2008 2
2009 2
2010 1
2011 3
2012 4
2013 3
2014 4
2015 3
2016 2
2017 6
2018 6
2020 5
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma.
Jagannath S, Lin Y, Goldschmidt H, Reece D, Nooka A, Senin A, Rodriguez-Otero P, Powles R, Matsue K, Shah N, Anderson LD Jr, Streetly M, Wilson K, Le HV, Swern AS, Agarwal A, Siegel DS. Jagannath S, et al. Among authors: swern as. Blood Cancer J. 2021 Jun 18;11(6):116. doi: 10.1038/s41408-021-00507-2. Blood Cancer J. 2021. PMID: 34145225 Free PMC article. Clinical Trial.
Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative.
Mikita JS, Mitchel J, Gatto NM, Laschinger J, Tcheng JE, Zeitler EP, Swern AS, Flick ED, Dowd C, Lystig T, Calvert SB. Mikita JS, et al. Among authors: swern as. Ther Innov Regul Sci. 2021 Jan;55(1):6-18. doi: 10.1007/s43441-020-00185-5. Epub 2020 Jun 22. Ther Innov Regul Sci. 2021. PMID: 32572772 Free PMC article. Review.
"To wheeze or not to wheeze": that is not the question--the sequel.
Bisgaard H, Swern AS, Knorr B. Bisgaard H, et al. Among authors: swern as. J Allergy Clin Immunol. 2012 Aug;130(2):531-2. doi: 10.1016/j.jaci.2011.10.047. Epub 2012 Feb 24. J Allergy Clin Immunol. 2012. PMID: 22365706 No abstract available.
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia.
Ahn IE, Farber CM, Davids MS, Grinblatt DL, Kay NE, Lamanna N, Mato A, Nabhan C, Kiselev P, Swern AS, Flick ED, Sullivan K, Sharman JP, Flowers CR. Ahn IE, et al. Among authors: swern as. Blood Adv. 2017 Nov 28;1(25):2433-2443. doi: 10.1182/bloodadvances.2017011262. eCollection 2017 Nov 28. Blood Adv. 2017. PMID: 29296893 Free PMC article.
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States.
Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP. Nabhan C, et al. Among authors: swern as. BMC Cancer. 2017 Mar 16;17(1):198. doi: 10.1186/s12885-017-3176-x. BMC Cancer. 2017. PMID: 28302090 Free PMC article. Clinical Trial.
Response to letter, 'immortal time bias in retrospective analysis'.
Dimopoulos MA, Swern AS, Li JS, Hussein M, Weiss L, Nagarwala Y, Baz R. Dimopoulos MA, et al. Among authors: swern as. Blood Cancer J. 2015 Jul 31;5(7):e327. doi: 10.1038/bcj.2015.55. Blood Cancer J. 2015. PMID: 26230951 Free PMC article. No abstract available.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Pleyer L, Döhner H, Dombret H, Seymour JF, Schuh AC, Beach CL, Swern AS, Burgstaller S, Stauder R, Girschikofsky M, Sill H, Schlick K, Thaler J, Halter B, Machherndl Spandl S, Zebisch A, Pichler A, Pfeilstöcker M, Autzinger EM, Lang A, Geissler K, Voskova D, Sperr WR, Hojas S, Rogulj IM, Andel J, Greil R. Pleyer L, et al. Among authors: swern as. Int J Mol Sci. 2017 Feb 15;18(2):415. doi: 10.3390/ijms18020415. Int J Mol Sci. 2017. PMID: 28212292 Free PMC article.
Reasons for initiation of treatment and predictors of response for patients with Rai stage 0/1 chronic lymphocytic leukemia (CLL) receiving first-line therapy: an analysis of the Connect® CLL cohort study.
Flowers CR, Nabhan C, Kay NE, Mato A, Lamanna N, Farber CM, Davids MS, Kiselev P, Swern AS, Sullivan K, Flick ED, Sharman JP. Flowers CR, et al. Among authors: swern as. Leuk Lymphoma. 2018 Oct;59(10):2327-2335. doi: 10.1080/10428194.2018.1427860. Epub 2018 Feb 7. Leuk Lymphoma. 2018. PMID: 29415595
45 results